Fed. Circ. Sends Wearable Tech IP Back To PTAB In Fitbit Fight

By Dani Kass (July 8, 2020, 10:44 PM EDT) -- The Federal Circuit on Wednesday gave Fitbit a second chance to invalidate claims of a Valencell patent for monitoring information like blood oxygen level and heart rate, and refused to narrow when joined parties can appeal Patent Trial and Appeal Board decisions.

The three-judge panel faulted the PTAB for not fully evaluating whether a claim was invalid in its final written decision, and then for refusing to allow an uncontroversial drafting error in the patent to be cleared up. It also shot down Valencell's arguments that Fitbit couldn't appeal these specific claims based on how the company's initial petition was framed....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!